Comorbidity considerations in geriatric oncology research

Ca-A Cancer Journal for Clinicians

Volumn 51, Issue 6, 2001, Pages 329-336

  Yates, Jerome W ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOPOIETIC GROWTH FACTOR;

AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RESEARCH; COMORBIDITY; CONTROLLED STUDY; COST; EVIDENCE BASED MEDICINE; GERIATRICS; HUMAN; INFORMATION SYSTEM; LEUKOPENIA; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL RECORD; ONCOLOGY; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0035570695     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.51.6.329     Document Type: Article

References (21)

1. Comorbidity
2. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients
3. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older
4. The elderly population: Opportunities for cancer prevention and detection
5. Pharmacology of antineoplastic agents in older cancer patients
6. Geriatric Oncology: Medical and psychosocial perspectives
7. Geriatric assessment in oncology
8. Under-representation of patients 65 years of age or older in cancer-treatment trials
9. Use of comorbidity scores for control of confounding in studies using administrative databases
10. Assessing illness severity: Does clinical judgment work?
11. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
12. Evaluations of patients with advanced cancer using the Karnofsky Performance Status
13. The Karnofsky Performance Status Scale: An examination of its reliability and validity in a research setting
14. Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and thiothylene thiophosphoramide
15. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
16. Comorbidity and functional status are independent in older cancer patients
17. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia
18. Further study of the increased mortality following transurethral prostatectomy; a chart based analysis
19. Problems of comorbidity in mortality after prostatectomy